Citation: P. Dahm et al., EFFICACY AND TECHNICAL COMPLICATIONS OF LONG-TERM CONTINUOUS INTRASPINAL INFUSIONS OF OPIOID AND OR BUPIVACAINE IN REFRACTORY NONMALIGNANT PAIN - A COMPARISON BETWEEN THE EPIDURAL AND THE INTRATHECAL APPROACH WITH EXTERNALIZED OR IMPLANTED CATHETERS AND INFUSION PUMPS/, The Clinical journal of pain, 14(1), 1998, pp. 4-16
Citation: P. Nitescu et al., CONTINUOUS-INFUSION OF OPIOID AND BUPIVACAINE BY EXTERNALIZED INTRATHECAL CATHETERS IN LONG-TERM TREATMENT OF REFRACTORY NONMALIGNANT PAIN, The Clinical journal of pain, 14(1), 1998, pp. 17-28
Citation: P. Dahm et al., HIGH THORACIC LOW CERVICAL, LONG-TERM INTRATHECAL (IT) INFUSION OF BUPIVACAINE ALLEVIATES REFRACTORY PAIN IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS - REPORT OF 2 CASES, Acta anaesthesiologica Scandinavica, 42(8), 1998, pp. 1010-1017
Authors:
APPELGREN L
NORDBORG C
SJOBERG M
KARLSSON PA
NITESCU P
CURELARU I
Citation: L. Appelgren et al., SPINAL EPIDURAL METASTASIS - IMPLICATIONS FOR SPINAL ANALGESIA TO TREAT REFRACTORY CANCER PAIN, Journal of pain and symptom management, 13(1), 1997, pp. 25-42
Authors:
ANEMAN A
EISENHOFER G
OLBE L
DALENBACK J
NITESCU P
FANDRIKS L
FRIBERG P
Citation: A. Aneman et al., SYMPATHETIC DISCHARGE TO MESENTERIC ORGANS AND THE LIVER - EVIDENCE FOR SUBSTANTIAL MESENTERIC ORGAN NOREPINEPHRINE SPILLOVER, The Journal of clinical investigation, 97(7), 1996, pp. 1640-1646
Authors:
APPELGREN L
JANSON M
NITESCU P
CURELARU L
Citation: L. Appelgren et al., CONTINUOUS INTRACISTERNAL AND HIGH CERVICAL INTRATHECAL BUPIVACAINE ANALGESIA IN REFRACTORY HEAD AND NECK PAIN, Anesthesiology, 84(2), 1996, pp. 256-272
Authors:
NITESCU P
SJOBERG M
APPELGREN L
CURELARU I
Citation: P. Nitescu et al., COMPLICATIONS OF INTRATHECAL OPIOIDS AND BUPIVACAINE IN THE TREATMENTOF REFRACTORY CANCER PAIN, The Clinical journal of pain, 11(1), 1995, pp. 45-62
Authors:
SJOBERG M
NITESCU P
APPELGREN L
CURELARU L
Citation: M. Sjoberg et al., LONG-TERM INTRATHECAL MORPHINE AND BUPIVACAINE IN PATIENTS WITH REFRACTORY CANCER PAIN - RESULTS FROM A MORPHINE- BUPIVACAINE DOSE REGIMEN OF 0.5 4.75 MG/ML/, Anesthesiology, 80(2), 1994, pp. 284-297